The use of medications in the secondary prevention of coronary artery disease in the Asian region

Dalal, Jamshed
Low, Lip-Ping
Dang, Van Phuoc
Background: Cardiovascular diseases, to which coronary artery disease (CAD) is a significant contributor, are a leading cause of long-term morbidity and mortality worldwide. In the years ahead, it is estimated that approximately half of the world's cardiovascular burden will occur in the Asian region. Currently there is a large gap in secondary prevention, with unrealized health gains resulting from underuse of evidence-based medications, including beta-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), aspirin and other antiplatelet agents, and lipid-lowering drugs. Despite the almost universal recommendation for these drugs in unstable CAD, their under-prescription is well documented for patients with acute heart failure, non-obstructive CAD, and for secondary prevention of CAD. Objective: This article reviews the burden of CAD in Asian countries together with guidelines supporting evidence-based medication use from a secondary prevention perspective. Methods: The MEDLINE database was searched from 2000 to 2013, inclusive, for country-specific data related to CAD and supplemented with unpublished registry data. Results: In the post-discharge setting following hospital admission for acute coronary syndromes, medication prescription rates were low. Beta-blocker prescription rates ranged from 49% in China to 99% in Singapore, ACE-inhibitor/ARB prescription rates ranged from 28% in China to 96% in Singapore, and lipid-lowering therapy rates ranged from 47% in China to 97% in Singapore. Aspirin/antiplatelet drug prescription rates ranged from 86% in Indonesia to 99.5% in Singapore. Recommendations are provided to improve patient outcomes and reduce the disease burden in Asia.
Chi tiết xin mời tham khảo tại http://repository.vnu.edu.vn/handle/VNU_123/32352 
Title: The use of medications in the secondary prevention of coronary artery disease in the Asian region
Authors: Dalal, Jamshed
Low, Lip-Ping
Dang, Van Phuoc
Keywords: Angiotensin converting enzyme inhibitors;Asian countries;Aspirin;Beta-blockers;Coronary artery disease
Issue Date: 2015
Publisher: INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
Citation: ISIKNOWLEDGE
Description: CURRENT MEDICAL RESEARCH AND OPINION Volume: 31 Issue: 3 Pages: 423-433 Published: MAR 2015 ; TNS05746
URI: http://www.tandfonline.com/doi/abs/10.1185/03007995.2015.1010035?src=recsys&journalCode=icmo20
http://repository.vnu.edu.vn/handle/VNU_123/32352
ISSN: 0300-7995
Appears in Collections:Bài báo của ĐHQGHN trong Web of Science

Nhận xét

Bài đăng phổ biến từ blog này

Xây dựng quy trình định lượng flurbiprofen trong viên nénbao phim 100 mg bằng phương pháp sắc ký lỏng hiệu năng cao ghép đầu dò diode-array

BTEX pollution caused by motorcycles in the megacity of HoChiMinh

Cultural Differences: A Barrier to Native English Teachers in English as a Foreign Language Contexts